Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Female Breast Cancer Patients”

1,314 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 1,314 results

Early research (Phase 1)Study completedNCT00002854
What this trial is testing

High-Dose Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Advanced Cancer

Who this might be right for
Cancer
City of Hope Medical Center 33
Not applicableStudy completedNCT01220960
What this trial is testing

Art Therapy Intervention for Breast Cancer Patients

Who this might be right for
Breast Cancer
Dr. Sarkis Meterissian 64
Early research (Phase 1)Study completedNCT00496860
What this trial is testing

Safety and Efficacy Study of ALT-801 to Treat Progressive Metastatic Malignancies

Who this might be right for
Progressive Metastatic Malignancies
Altor BioScience 26
Testing effectiveness (Phase 2)Study completedNCT00052351
What this trial is testing

Vaccine Therapy Plus Sargramostim and Chemotherapy in Treating Women With Stage II or Stage III Breast Cancer

Who this might be right for
Breast Cancer
National Cancer Institute (NCI)
Not applicableStudy completedNCT05977829
What this trial is testing

Endometrial Malignancy in Breast Cancer Patients With or Without AUB

Who this might be right for
Endometrial Neoplasms
University of Campania Luigi Vanvitelli 283
Testing effectiveness (Phase 2)Study completedNCT00002585
What this trial is testing

Pyrazoloacridine in Treating Women With Metastatic Breast Cancer

Who this might be right for
Breast Cancer
Barbara Ann Karmanos Cancer Institute 20
Testing effectiveness (Phase 2)Study completedNCT00003565
What this trial is testing

Docetaxel in Treating Patients With Solid Tumors

Who this might be right for
Bladder CancerBreast CancerHead and Neck Cancer+2 more
Alliance for Clinical Trials in Oncology 109
Not applicableStudy completedNCT00900406
What this trial is testing

Collecting and Storing Tissue and DNA Samples From Patients Undergoing a Donor Stem Cell Transplant

Who this might be right for
Breast CancerChronic Myeloproliferative DisordersGestational Trophoblastic Tumor+9 more
Vanderbilt-Ingram Cancer Center 190
Not applicableStudy completedNCT06161233
What this trial is testing

Pilot Study of the eHealth Application "Cancer Patients Better Life Experience" (CAPABLE) - Italy

Who this might be right for
Renal Cell Carcinoma MetastaticBreast CancerHead and Neck Cancer+4 more
Istituti Clinici Scientifici Maugeri SpA 56
Not applicableStudy completedNCT01931644
What this trial is testing

At-Home Research Study for Patients With Autoimmune, Inflammatory, Genetic, Hematological, Infectious, Neurological, CNS, Oncological, Respiratory, Metabolic Conditions

Who this might be right for
All Diagnosed Health ConditionsADD/ADHDAlopecia Areata+58 more
Sanguine Biosciences 17,667
Testing effectiveness (Phase 2)Study completedNCT03450044
What this trial is testing

Immunogenicity and Safety of DCs in Breast Cancer

Who this might be right for
Breast Cancer Female
Fundación Salud de los Andes 15
Not applicableStudy completedNCT01643148
What this trial is testing

The Tetrad BMI, Leptin, Leptin/Adiponectin (L/A) Ratio and CA-15-3 is a Reliable Biomarker of Breast Cancer

Who this might be right for
Female Breast Carcinoma
Materno-Perinatal Hospital of the State of Mexico 88
Testing effectiveness (Phase 2)Ended earlyNCT05070247
What this trial is testing

TAK-500 With or Without Pembrolizumab in Adults With Select Locally Advanced or Metastatic Solid Tumors

Who this might be right for
Pancreatic CancerHepatocellular CancerMesothelioma+7 more
Takeda 61
Testing effectiveness (Phase 2)UnknownNCT01168505
What this trial is testing

Iron Supplement in the Prevention of Anemia in Female Breast Cancer Patients

Who this might be right for
Breast Cancer
Instituto do Cancer do Estado de São Paulo 100
Large-scale testing (Phase 3)Study completedNCT01583426
What this trial is testing

Nanoparticle-based Paclitaxel vs Solvent-based Paclitaxel as Part of Neoadjuvant Chemotherapy for Early Breast Cancer (GeparSepto)

Who this might be right for
Tubular Breast Cancer Stage IIMucinous Breast Cancer Stage IIBreast Cancer Female NOS+5 more
GBG Forschungs GmbH 1,229
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06254066
What this trial is testing

Adebrelimab Combined With Fluzoparib in HRD-positive HR +/HER2- Advanced Breast Cancer

Who this might be right for
Female Breast Cancer PatientsHistopathologically Confirmed Advanced HR +/HER2-invasive Breast CancerHRD Positive Advanced Breast Cancer
Zhejiang Cancer Hospital 40
Large-scale testing (Phase 3)WithdrawnNCT00301886
What this trial is testing

S0308 Zoledronate or Ibandronate in Preventing Bone Problems in Women With Stage IV Breast Cancer That Has Spread to the Bone

Who this might be right for
Breast CancerHypercalcemia of MalignancyMetastatic Cancer+1 more
SWOG Cancer Research Network
Not applicableStudy completedNCT05484180
What this trial is testing

The Effect of Guided Imagery Based on the Health Promotion Model on the Quality of Life in Breast Cancer Patients

Who this might be right for
Breast Cancer Female
Ataturk University 68
Not applicableNot Yet RecruitingNCT07124403
What this trial is testing

DESIR. Evaluation of the Pre-therapeutic Activity of Dihydropyrimidine dEShydrogenase (DPD) in Patients With Cancer and/or Renal Failure

Who this might be right for
Renal ImpairmentDigestive CancersBreast Cancer
Centre Hospitalier Universitaire de Besancon 742
Not applicableStudy completedNCT06595758
What this trial is testing

This Study Investigates the Impact of Single Nucleotide Polymorphisms in Genes Involved in the Pharmacokinetics and Toxicity of Doxorubicin (DOX) in Egyptian Female Patients with Breast Cancer. It Also Aims to Explore the Association of Pretreatment Neutrophil to Lymphocyte Ratio to PCR

Who this might be right for
Breast Cancer
Menoufia University 100
Load More Results